Fundoplication vs. Magnetic Sphincter Augmentation vs. TIF: If and when should I use them?
May 1, 2021 8:10am ‐ May 1, 2021 8:30am
Identification: 7.1
Presentation style: Debate
- Upon completion of this activity, participants will be able to describe different strategies for the treatment of gastroesophageal reflux, whilst concurrently minimising post-procedure side effects.
- Upon completion of this activity, participants will be able to assess and compare alternative procedures for the treatment of gastroesophageal reflux.
- Upon completion of this activity, participants will be able to evaluate the advantages and disadvantages of different procedures for the treatment of gastroesophageal reflux.
- To define the heterogeneity of GERD patients to prove that one size does not fit all.
Initiation of Colon Cancer Screening: 45 or 50 years old
May 1, 2021 8:10am ‐ May 1, 2021 8:30am
Identification: 9.1
Presentation Style: Debate
- Describe the epidemiologic trends of EOCRC in the US
- List the clinical and molecular features of EOCRC
- To understand temporal trends in the incidence of colorectal cancer (CRC) in the US
- To learn about the results of modeling the impacts of starting screening at age 45 years
- To appreciate the need for a stronger focus on the under/never screened age 50-75 years
Monitoring and treating a lifetime of eosinophilic esophagitis
May 1, 2021 8:30am ‐ May 1, 2021 8:50am
Identification: 7.2
Presentation style: Interview
- Understand the diagnostic criteria for EoE
- Describe the rationale for maintenance treatment for EoE
- Recognize the need for ongoing monitoring of EoE treatment response
The changing landscape of fecal microbial transplantation (FMT)
May 1, 2021 8:30am ‐ May 1, 2021 8:50am
Identification: 9.2
Presentation style: Interview
- To gain an understanding of the evolution of FMT over time.
- To describe the FDA regulations surrounding FMT.
- To develop an appreciation for how COVID-19 has affected use of FMT in clinical practice.
- To recognize the potential indications for FMT and understand the efficacy of FMT in the treatment of C. difficile infection (CDI), IBD and IBS
Screening and surveillance of Barrett’s Esophagus: Are the guidelines still helpful?
May 1, 2021 8:50am ‐ May 1, 2021 9:05am
Identification: 7.3
Presentation style: Pitfall
- To discuss the limitations of current screening and surveillance strategies in patients with Barrett’s esophagus
- To highlight the advances in non-endoscopic approaches to screening for Barrett’s esophagus and esophageal adenocarcinoma
- To provide best practice advice to optimize detection of Barrett’s esophagus related neoplasia